Kerecis Drives the Fish‑Skin Conversation at Leading European Wound Conference – EWMA‑DEWU 2026

Bremen, Germany – May 4, 2026 — Kerecis, the company pioneering the use of sustainably sourced intact fish skin in cellular therapy and tissue regeneration, will play a prominent scientific and educational role at the EWMA‑DEWU 2026 Conference, taking place May 6–8 at the Messe & Congress Centrum Bremen in Bremen, Germany.

This year EWMA, The European Wound Management Associations meeting is held this year in conjunction with the Deutscher Wundkongress (DEWU), combining two major wound care congresses into a single forum for scientific exchange, education, and clinical discussion.

At this year’s conference, Kerecis will highlight growing clinical experience with intact fish‑skin grafts across a broad range of wound indications, supported by two Kerecis‑led scientific symposia, multiple oral and poster presentations, and direct engagement with clinicians at Booth D30, located adjacent to the EWMA Arena.

Scientific Symposia

Kerecis will host two scientific symposia during EWMA‑DEWU 2026.
On Wednesday, May 6 (11:30–12:30 CET), Kerecis will co‑host a multidisciplinary symposium titled “Implementing Clinical and Cost Improvement Programs to Deliver Value‑Based Wound Care,” held in Hall 6, Room 5A.
The session will feature:

• Caroline Dowsett, PhD, Tissue Viability Nurse Consultant
• Sian Fumarola, RGN, MSc, Head of Clinical Procurement
• Marcus Philipp Moll, Medical Advisor, Coloplast GmbH

The symposium will explore how structured, evidence‑based approaches can support clinical and economic improvement in wound care delivery. In this context, established evidence related to advanced wound dressings, including Biatain®, will be referenced.

On Friday, May 8 (11:00–12:00 CET), Kerecis will host a second symposium titled “The Utility of Intact Fish Skin in the Pediatric Population,” held in the Focke‑Wulf Auditorium.
The session will be moderated by John Lantis II, MD, and will include:

• Prof. Guido Ciprandi, MD, PhD, pediatric surgeon and EWMA Council member
• Dr. Helen Glosse, Senior Physician, Pediatric Surgery, Klinikum Stuttgart
• Dr. Matthias Schaffert, University Clinic for Pediatric and Adolescent Surgery, Salzburg

The symposium will focus on clinical experience and emerging evidence supporting the use of intact fish‑skin grafts in pediatric wound management.

Abstracts and Posters

Kerecis‑related research will be widely represented across the EWMA‑DEWU 2026 scientific program, with five accepted abstracts addressing intact fish‑skin technology:

Oral Presentation

• Dr. Petra Kotzbeck (Austria): Comparative Wound Healing Dynamics Using Intact and Particularized Fish-Skin Grafts

Poster Presentations

• Prof. Lars‑Peter Kamolz (Austria): Epidemiology of Civilian Ukrainian War Casualties in Austria
• Prof. Lars‑Peter Kamolz (Austria): Ukrainian War Casualties: Complex Injuries and High Bacterial Load – Experiences from a Trauma Center
• Dr. Thomas Kapp (Switzerland): Therapieoption bei aussichtslosen Wunden: Intact Fish-Skin Graft
• Dr. Magdalena Maj (Poland): Intact Fish Skin Graft as an Alternative to Split‑Thickness Skin Grafting in the Management of Diabetic Foot Ulcers – A Prospective Observational Study

In addition, one poster related to advanced wound dressings has been accepted, addressing optimization of exudate management in clinical practice.

Exhibition and Education

Throughout the congress, clinicians are invited to engage with the Kerecis team at Booth D30, located next to the EWMA Arena. The booth will feature product demonstrations, short educational sessions at the Speaker’s Corner, and informal scientific exchange focused on intact fish‑skin technology.

Kerecis will also host its Taste of Iceland educational event on the evening of Wednesday, May 6, bringing together invited clinicians for a focused scientific session and informal networking centered on evidence‑based wound care and innovation.